drugset / Trial / NCT06726395

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

NCT06726395

Phase 4 Recruiting 420 enrolled Region Skane
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.

Timeline

Start
2025-03-10
Primary completion
2028-04
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzylpenicillin Unknown 1 g
Subject Benzylpenicillin Unknown 1200 mg
Comparator cloxacillin Other / unclassified 2 g